Report
Independent transcriptional reprogramming and apoptosis induction by cisplatin
Downloads and Tools
Volume 11, Issue 18 September 15, 2012
Pages 3472 - 3480
http://dx.doi.org/10.4161/cc.21789
Keywords: N-acetyl-cysteine, autophagy, bongkrekic acid, cyclosporine A, glutathione, large-amplitude swelling
Authors: Lorenzo Galluzzi, Ilio Vitale, Laura Senovilla, Tobias Eisenberg, Didac Carmona-Gutiérrez, Erika Vacchelli, Thomas Robert, Hugues Ripoche, Nora Jägemann, Caroline Paccard, Nicolas Servant, Philippe Hupé, Vladimir Lazar, Philippe Dessen, Emmanuel Barillot, Hans Zischka, Frank Madeo and Guido Kroemer
View affiliations Hide affiliations
- Lorenzo Galluzzi
-
Université Paris Descartes/Paris V; Sorbonne Paris Cité; Paris, France; Institut Gustave Roussy; Villejuif, France
- Ilio Vitale
-
Institut Gustave Roussy; Villejuif, France; INSERM; U848; Villejuif, France; Université ParisSud/Paris XI; Villejuif, France
- Laura Senovilla
-
Institut Gustave Roussy; Villejuif, France; INSERM; U848; Villejuif, France; Université ParisSud/Paris XI; Villejuif, France
- Tobias Eisenberg
-
Institute of Molecular Biosciences; University of Graz; Graz, Austria
- Didac Carmona-Gutiérrez
-
Institute of Molecular Biosciences; University of Graz; Graz, Austria
- Erika Vacchelli
-
Institut Gustave Roussy; Villejuif, France; INSERM; U848; Villejuif, France; Université ParisSud/Paris XI; Villejuif, France
- Thomas Robert
-
Institut Gustave Roussy; Villejuif, France; Unité de Génomique Fonctionnelle et Bioinformatique; Institut Gustave Roussy; Villejuif, France
- Hugues Ripoche
-
Institut Gustave Roussy; Villejuif, France; CNRS; UMR8200; Villejuif, France
- Nora Jägemann
-
Institute of Toxicology; Helmholtz Center Munich; German Research Center for Environmental Health; Neuherberg, Germany
- Caroline Paccard
-
Institut Curie; Paris, France; INSERM; U900; Paris, France; Mines ParisTech; Fontainebleau, France
- Nicolas Servant
-
Institut Curie; Paris, France; INSERM; U900; Paris, France; Mines ParisTech; Fontainebleau, France
- Philippe Hupé
-
Institut Curie; Paris, France; INSERM; U900; Paris, France; Mines ParisTech; Fontainebleau, France; CNRS; UMR144; Paris, France
- Vladimir Lazar
-
Institut Gustave Roussy; Villejuif, France; Unité de Génomique Fonctionnelle et Bioinformatique; Institut Gustave Roussy; Villejuif, France
- Philippe Dessen
-
Institut Gustave Roussy; Villejuif, France; Unité de Génomique Fonctionnelle et Bioinformatique; Institut Gustave Roussy; Villejuif, France; INSERM; U985; Villejuif, France
- Emmanuel Barillot
-
Institut Curie; Paris, France; INSERM; U900; Paris, France; Mines ParisTech; Fontainebleau, France
- Hans Zischka
-
Institute of Toxicology; Helmholtz Center Munich; German Research Center for Environmental Health; Neuherberg, Germany
- Frank Madeo
-
Institute of Molecular Biosciences; University of Graz; Graz, Austria
- Guido Kroemer
-
Corresponding author: kroemer@igr.fr
Université Paris Descartes/Paris V; Sorbonne Paris Cité; Paris, France; INSERM; U848; Villejuif, France; Metabolomics Platform; Institut Gustave Roussy; Villejuif, France; Pôle de Biologie; Hôpital Européen Georges Pompidou; AP-HP; Paris, France; Centre de Recherche des Cordeliers; Paris, France
Abstract:
Neither the molecular mechanisms whereby cancer cells intrinsically are or become resistant to the DNA-damaging agent cisplatin nor the signaling pathways that account for cisplatin cytotoxicity have thus far been characterized in detail. In an attempt to gain further insights into the molecular cascades elicited by cisplatin (leading to resistance or underpinning its antineoplastic properties), we comparatively investigated the ability of cisplatin, C2-ceramide and cadmium dichloride, alone or in the presence of an array of mitochondrion-protective agents, to trigger the permeabilization of purified mitochondria. In addition, we compared the transcriptional response triggered by cisplatin, C2-ceramide and cadmium dichloride in non-small cell lung carcinoma A549 cells. Finally, we assessed the capacity of cisplatin, C2-ceramide and cadmium dichloride to reduce the clonogenic potential of a battery of yeast strains lacking proteins involved in the regulation of cell death, DNA damage signaling and stress management. This multipronged experimental approach revealed that cisplatin elicits signaling pathways that are for the most part “private,” i.e., that manifest limited overlap with the molecular cascades ignited by other inducers of mitochondrial apoptosis, and triggers apoptosis mainly in a transcription-independent fashion. Indeed, bona fide cisplatin-response modifiers that we have recently identified by a functional genome-wide siRNA screen are either not transcriptionally regulated during cisplatin-induced cell death or their transcriptional modulation reflects the activation of an adaptive response promoting cisplatin resistance
Received: July 26, 2012; Accepted: August 8, 2012; Published Online: August 23, 2012
Preview: